Mice expressing the α1B-adrenergic receptor induces a synucleinopathy with excessive tyrosine nitration but decreased phosphorylation

Journal of Neurochemistry

Volumn 83, Issue 3, 2002, Pages 623-634

  Papay, Robert ^a   Zuscik, Michael J ^a,b   Ross, Sean A ^a   Yun, June ^a   McCune, Dan F ^a   Gonzalez Cabrera, Pedro ^a   Gaivin, Robert ^a   Macklin, Wendy B ^a   Drazba, Judy ^a   Perez, Dianne M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Adrenergic; Receptor; Synuclein; Transgenic

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA SYNUCLEIN; META TYROSINE; TERAZOSIN; UBIQUITIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INCLUSION; CEREBELLUM; CONTROLLED STUDY; DEGENERATIVE DISEASE; GENE OVEREXPRESSION; IMMUNOHISTOCHEMISTRY; MOUSE; NERVE CELL; NITRATION; NONHUMAN; OLIGODENDROGLIA; PARKINSONISM; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PURKINJE CELL; SHY DRAGER SYNDROME; SIGNAL TRANSDUCTION; SYNUCLEINOPATHY; TRANSGENIC MOUSE;

ADRENERGIC ALPHA-ANTAGONISTS; ALPHA-SYNUCLEIN; ANIMALS; BODY WEIGHT; BRAIN; CEREBELLUM; DISEASE MODELS, ANIMAL; FEMALE; INCLUSION BODIES; MACROMOLECULAR SUBSTANCES; MALE; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; MULTIPLE SYSTEM ATROPHY; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES; NEURONS; NITRATES; OLIGODENDROGLIA; PHOSPHORYLATION; PRAZOSIN; RECEPTORS, ADRENERGIC, ALPHA-1; SPINAL CORD; SURVIVAL RATE; SYNUCLEINS; TYROSINE; UBIQUITIN;

ANIMALIA; MUS MUSCULUS; PARKINSONIA;

EID: 18644371727     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2002.01170.x     Document Type: Article

References (52)

1. Anyukovsky E. P. and Rosen M. R. (1991) Abnormal automatic rhythms in ischemic purkinje fibers are modulated by a specific alpha1-adrenergic receptor subtype. Circulation 83, 2076-2082.
2. Bergles D. E., Doze V. A., Madison D. V. and Smith S. J. (1996) Excitatory actions of norepinephrine on mutiple classes of hippocampal CA1 interneurons. J Neurosci. 16, 572-585.
3. Cavalli A., Lattion A.-L., Hummler E., Nenniger M., Pedrazzini Aubert J.-F., Michel M. C., Yang M., Lembo G., Vecchione C., Mostardini M., Schmidt A., Beermann F. and Cotecchia S. (1997) Decreased blood pressure response in mice deficient of the alpha1b-adrenergic receptor. Proc. Natl. Acad. Sci. USA 94, 11589-11594.
4. Chen L., Xin X., Eckhart A. D., Yang N. and Faber J. E. (1995) Regulation of vascular smooth muscle growth by alpha 1-adrenoreceptor subtypes in vitro and in situ. J Biol. Chem. 270, 30980-30988.
5. Conway K. A., Lee S. J., Rochet J. C., Ding T. T., Harper J. D., Williamson R. E. and Lansbury P. T. Jr (2000) Accelerated oligomerization by Parkinson's disease linked alpha-synuclein mutants. Ann. NY Acad. Sci. 920, 42-45.
6. Cotecchia S., Schwinn D. A., Randall R. R., Lefkowitz R. J., Caron M. G. and Kobilka B. K. (1988) Molecular cloning and expression of the cDNA for the hamster alpha 1-adrenergic receptor. Proc. Natl. Acad. Sci. USA 85, 7159-7163.
7. Davidson W. S., Jonas A., Clayton D. F. and George J. M. (1998) Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes. J Biol. Chem. 17, 9443-9449.
8. Ellis C. E., Schwartzberg P. L., Grider T L., Fink D. W. and Nussbaum R. L. (2001) Alpha-synuclein is phosphorylated by members of the Src family of protein-tyrosine kinases. J Biol. Chem. 276, 3879-3884.
9. Feany M. B. and Bender W. W. (2000) A Drosophila model of Parkinson's disease. Nature 23, 394-398.
10. Fujiwara H., Hasegawa M., Dohmae N., Kawashima A., Masliah E., Goldberg M. S., Shen J., Takio K. and Iwatsubo T. (2002) Alpha-synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell. Biol. 4, 160-164.
11. Giasson B. I., Duda J. E., Murray I. V., Chen Q., Souza J. M., Hurtig H. I., Ischiropoulos H., Trojanowski J. Q. and Lee V. M. (2000) Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy. Science 290, 985-989.
12. Gilman S., Low P., Quinn N., Albanese A., Ben-Shlomo Y., Fowler C., Kaufmann H., Klockgether T., Lang A., Lantos P., Litvan I., Mathias C., Oliver E., Robertson D., Schatz I. and Wenning G. (1998) Consensus statement on the diagnosis of multiple system atrophy. American Autonomic Society and American. Clin. Auton. Res. 8, 359-362.
13. 1-adrenergic receptor subtypes. Cell Signal. 8, 323-333.
14. Heal D. J. (1990) The effects of drugs on behavioural models of central noradrenergic function. In: The Pharmacology of Noradrenaline in the Central Nervous System (D. J. Heal and D. A. Marsden, eds), pp. 266-315. Oxford University Press, New York.
15. Hrometz S. L., Edelmann S. E., McCune D. F., Olges J. R., Hadley R. W., Perez D. M. and Piascik M. T. (1999) Expression of multiple alpha1-adrenoceptors on vascular smooth muscle: Correlation with the regulation of contraction. J. Pharmacol. Exp. Ther. 290, 452-463.
16. Jeffries W. B. and Pettinger W. A. (1989) Adrenergic signal transduction in the kidney. Miner. Electrolyte Metab. 15, 5-15.
17. Jensen P. H., Nielsen M. S., Jakes R., Dotti C. G. and Goedert M. (1998) Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation. J. Biol. Chem. 273, 26292-26294.
18. Kahle P. J., Neumann M., Ozmen L., Muler V., Jacobsen H., Spooren W., Fuss B., Mallon B., Macklin W. B., Fujiwara H., Hasegawa M., Iwatsubo T., Kretzschmar H. A. and Häass C. (2002) Hyperphosphorylation and insolubility of α-synuclein in transgenic mouse oligodendrocytes. EMBO Reports 3, 583-588.
19. Kruger R., Kuhn W., Muller T., Woitalla D., Graeber M., Kosel S., Przuntek H., Epplen J. T., Schols L. and Riess O. (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet. 18, 106-108.
20. +2 release in Bergmann glial cells in situ. J. Neurosci. 19, 8401-8408.
21. Kume A., Takahashi A., Hashizume Y. and Asai J. (1991) A histometrical and comparative study on Purkinje cell loss and olivary nucleus cell loss in multiple system atrophy. J. Neurol. Sci. 101, 178-186.
22. Kunos G. and Ishac E. J. N. (1987) Mechanism of inverse regulation of alpha 1- and beta-adrenergic receptors. Biochem. Pharmacol. 36, 1185-1191.
23. Lantos P. L. (1998) The definition of multiple system atrophy: A review of recent developments. J. Neuropathol. Exp. Neurol. 57, 1099-1111.
24. Leech C. J. and Faber J. E. (1996) Different alpha-adrenoceptor subtypes mediate constriction of arterioles and venules. Am. J. Physiol. 270, H710-H722.
25. Lomasney J. W., Cotecchia S., Lorenz W., Leung W. Y., Schwinn D. A., Yang-Feng T. L., Braunstein M., Lefkowitz R. J. and Caron M. G. (1991) Molecular cloning and expression of the cDNA for the alpha 1A-adrenergic receptor. The gene for which is located on human chromosome 5. J. Biol. Chem. 266, 6365-6369.
26. Lyras L., Perry R. H., Perry E. K., Ince P. G., Jenner A., Jenner P. and Halliwell B. (1998) Oxidative damage to proteins, lipids, and DNA in cortical brain regions from patients with dementia with Lewy bodies. J. Neurochem. 71, 302-312.
27. Marek G. J. and Aghajanian K. (1999) Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release. Brain Res. 825, 161-171.
28. Masliah E., Rockenstein E., Veinbergs I., Mallory M., Hashimoto M., Takeda A., Sagara Y., Sisk A. and Mucke L. (2000) Dopaminergic loss and inclusion body formation in alpha-synuclein mice: Implications for neurodegenerative disorders. Science 287, 1265-1269.
29. 1-receptor-lined second messenger pathway. Brain Res. 546, 83-95.
30. Okochi M., Walter J., Koyama A., Nakajo S., Baba M., Iwatsubo T., Meijer L., Kahle P. J. and Haass C. (2000) Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein. J. Biol. Chem. 275, 390-397.
31. Papp M. I., Kahn J. E. and Lantos P. L. (1989) Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J. Neurol. Sci. 94, 79-100.
32. Paxinou E., Chen Q., Weisse M., Giasson B. I., Norris E. H., Rueter S. M., Trojanowski J. Q., Lee V. M. and Ischiropoulos H. (2001) Induction of alpha-synuclein aggregation by intracellular nitrative insult. J. Neurosci. 21, 8053-8061.
33. 1B-adrenergic receptor causes a "seizure plus" syndrome'. Nat. Med. 7, 132-133.
34. 1d-adrenergic receptor cDNA. Mol. Pharmacol. 40, 876-883.
35. 1a-subtype. Mol. Pharmacol. 46, 823-831.
36. 1-Adrenergic receptors: New insights and directions. J. Pharmacol. Exp. Ther. 298, 403-410.
37. Polymeropoulos M. H., Lavedan C., Leroy E., Ide S. E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E. S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W. G., Lazzarini A. M., Duvoisin R. C., Di Iorio G., Golbe L. I. and Nussbaum R. L. (1997) Mutation in the alphasynuclein gene identified in families with Parkinson's disease. Science 276, 2045-2047.
38. Probst-Cousin S., Rickert C. H., Schmid K. W. and Gullotta F. (1998) Cell death mechanisms in multiple system atrophy. J. Neuropathol. Exp. Neurol. 57, 814-821.
39. Pronin A. N., Morris A. J., Surguchov A. and Benovic J. L. (2000) Synucleins are a novel class of substrates for G protein-coupled receptor kinases. J. Biol. Chem. 275, 26515-26522.
40. van der Putten H., Wiederhold K. H., Probst A., Barbieri S., Mistl C., Danner S., Kauffmann S., Hofele K., Spooren W. P., Ruegg M. A., Lin S., Caroni P., Sommer B., Tolnay M. and Bilbe G. (2000) Neuropathology in mice expressing human alpha-synuclein. J. Neurosci. 15, 6021-6029.
41. Rossier O., Abuin L., Fanelli F., Leonardi A. and Cotecchia S. (1999) Inverse agonism and neutral antagonism at alpha (1a)- and alpha (1b)-adrenergic receptor subtypes. Mol. Pharmacol. 56, 858-866.
42. Sakakibara R., Hattori T., Uchiyama T., Suenaga T., Takahashi H., Yamanishi T., Tegoshi K.-i. and Sekita N. (2000) Are alpha-blockers involved in lower urinary tract dysfunction in multiple system atrophy? A comparison of prazosin and moxisylyte. J. Auton. Nerv. Sys. 79, 191-195.
43. Seppi K., Puschban Z., Stefanova N., Scherfler C., Mueller J., Poewe W. and Wenning G. K. (2001) Overstimulation of the alpha1B-adrenergic receptor causes a 'seizure plus' syndrome. Nat. Med. 7, 132.
44. Sharon R., Goldberg M. S., Bar-Jose I., Betensky R. A., Shen J. and Selkoe D. J. (2001) Alpha-synuclein occurs in lipid-rich high molecular weight complexes, binds to fatty acids, and shows homology to the fatty acid-binding proteins. Proc. Natl. Acad. Sci. USA 98, 9110-9115.
45. Sirvia J. and MacDonald E. (1999) Central alpha 1-adrenoceptors: Their role in the modulation of attention and memory formation. Pharmacol. Ther. 83, 49-65.
46. Souza J. M., Giasson B. I., Chen Q., Lee V. M.-Y. and Ischiropoulos H. (2000) Dityrosine cross-linking promotes formation of stable α-synuclein polymers. J Biol. Chem. 275, 18344-18349.
47. Stone E. A., Zhang Y., Rosengarten H., Yeretsian J. and Quartermain D. (1999) Brain alpha1-adrenergic neurotransmission is necessary for behavioral activation to environmental change in mice. Neuroscience 94, 1245-1252.
48. Stone E. A., Lin Y., Itteera A. and Quarterman D. (2001) Pharmacological evidence for the role of central alpha1B-adrenoceptors in the motor activity and spontaneous movement of mice. Neuropharmacology 40, 254-261.
49. Takahashi T., Yamashita H., Nakamura T., Nagano Y. and Nakamura S. (2002) Tyrosine 125 of alpha-synuclein plays a critical role for dimerization following nitrative stress. Brain Res. 938, 73-80.
50. 1b-adrenergic receptor promoter. Mol. Pharmacol. 56, 1288-1297.
51. 1b-adrenergic receptor causes apoptotic neurodegeneration: A multiple system atrophy. Nat. Med. 6, 1388-1394.
52. 1b-adrenergic receptor. J. Biol. Chem. 276, 13738-13743.